MX336870B - Uso de oligosacaridos sinteticos polisulfatados como agentes de desbridamiento de heridas. - Google Patents

Uso de oligosacaridos sinteticos polisulfatados como agentes de desbridamiento de heridas.

Info

Publication number
MX336870B
MX336870B MX2012009675A MX2012009675A MX336870B MX 336870 B MX336870 B MX 336870B MX 2012009675 A MX2012009675 A MX 2012009675A MX 2012009675 A MX2012009675 A MX 2012009675A MX 336870 B MX336870 B MX 336870B
Authority
MX
Mexico
Prior art keywords
wound
cleaning agents
oligosaccharides
synthetic
polysulphated oligosaccharides
Prior art date
Application number
MX2012009675A
Other languages
English (en)
Other versions
MX2012009675A (es
Inventor
Laurent Apert
Christelle Laurensou
Dominique Nicot
Original Assignee
Urgo Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Urgo Lab filed Critical Urgo Lab
Publication of MX2012009675A publication Critical patent/MX2012009675A/es
Publication of MX336870B publication Critical patent/MX336870B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F13/00—Bandages or dressings; Absorbent pads
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7016—Disaccharides, e.g. lactose, lactulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/18—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing inorganic materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
    • A61L15/28—Polysaccharides or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/23—Carbohydrates
    • A61L2300/232—Monosaccharides, disaccharides, polysaccharides, lipopolysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures

Abstract

La presente invención se refiere al uso de la menos un compuesto seleccionado de oligosacáridos sintéticos polisulfatados con de 1 a 4 unidades de monosacáridos, sus sales y complejos, como agente de desbridamiento de una herida. La invención se aplica en particular a la preparación de apósitos destinados al desbridamiento de heridas.
MX2012009675A 2010-02-17 2011-02-16 Uso de oligosacaridos sinteticos polisulfatados como agentes de desbridamiento de heridas. MX336870B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1051142A FR2956322A1 (fr) 2010-02-17 2010-02-17 Utilisation d'oligosaccharides polysulfates synthetiques comme agents de detersion d'une plaie.
PCT/FR2011/050329 WO2011101594A1 (fr) 2010-02-17 2011-02-16 Utilisation d'oligosaccharides polysulfates synthetiques comme agents de detersion d'une plaie

Publications (2)

Publication Number Publication Date
MX2012009675A MX2012009675A (es) 2013-02-11
MX336870B true MX336870B (es) 2016-02-04

Family

ID=42813433

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012009675A MX336870B (es) 2010-02-17 2011-02-16 Uso de oligosacaridos sinteticos polisulfatados como agentes de desbridamiento de heridas.

Country Status (16)

Country Link
US (1) US8940325B2 (es)
EP (1) EP2536413B1 (es)
JP (2) JP5889804B2 (es)
KR (1) KR101846036B1 (es)
CN (1) CN102762212B (es)
AU (1) AU2011217040B2 (es)
BR (1) BR112012020739A2 (es)
CA (1) CA2788350C (es)
ES (1) ES2578327T3 (es)
FR (2) FR2956322A1 (es)
MX (1) MX336870B (es)
PL (1) PL2536413T3 (es)
PT (1) PT2536413T (es)
RU (1) RU2601899C2 (es)
SG (1) SG182798A1 (es)
WO (1) WO2011101594A1 (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2956322A1 (fr) * 2010-02-17 2011-08-19 Urgo Lab Utilisation d'oligosaccharides polysulfates synthetiques comme agents de detersion d'une plaie.
FR2991876B1 (fr) 2012-06-13 2014-11-21 Vivacy Lab Composition, en milieu aqueux, comprenant au moins un acide hyaluronique et au moins un sel hydrosoluble de sucrose octasulfate
FR2993182B1 (fr) * 2012-07-13 2014-10-17 Urgo Lab Pansement a liberation prolongee d'actifs
CN102755664B (zh) * 2012-07-20 2014-03-26 河南科技大学 用于寒区外伤创面的急救敷料及其制备方法
FR2999581B1 (fr) * 2012-12-18 2015-05-01 Urgo Lab Procede d'incorporation d'agents actifs au sein d'une mousse polyurethane hydrophile
US10113879B2 (en) 2014-03-03 2018-10-30 Apple Inc. Hierarchy of tools for navigation
FR3026949A1 (fr) * 2014-10-09 2016-04-15 Urgo Lab Composition cosmetique et/ou dermatologique pour la prevention et le traitement des varices sous cutanees
KR20170134572A (ko) 2015-04-06 2017-12-06 쓰리엠 이노베이티브 프로퍼티즈 컴파니 제거가능한 필름 형성 겔 조성물 및 이의 적용 방법
CN104926889A (zh) * 2015-05-24 2015-09-23 广西师范学院 蔗糖硫酸酯铜银类化合物及其制作方法和用途
JP2019510037A (ja) 2016-03-31 2019-04-11 ゴジョ・インダストリーズ・インコーポレイテッド 抗菌ペプチド刺激性洗浄組成物
EP3436041B1 (en) 2016-03-31 2023-05-24 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
AU2017365019A1 (en) 2016-11-23 2019-07-11 Gojo Industries, Inc. Sanitizer composition with probiotic/prebiotic active ingredient
FR3064488B1 (fr) 2017-03-31 2021-01-01 Urgo Rech Innovation Et Developpement Composition contenant un derive de cellulose, un plastifiant, un solvant volatil et un actif, ses utilisations comme pansement

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA869530B (en) * 1985-12-24 1987-10-28 Marion Laboratories Inc Use of synthetic sulfated saccharides to enhance wound healing
AU607690B2 (en) * 1985-12-24 1991-03-14 Marion Laboratories, Inc. Use of synthetic sulfated saccharides to enhance wound healing
US4912093A (en) * 1986-10-01 1990-03-27 Marion Laboratories, Inc. Use of synthetic sulfated saccharides to enhance wound healing
SE8702254D0 (sv) * 1987-05-29 1987-05-29 Kabivitrum Ab Novel heparin derivatives
US5246708A (en) * 1987-10-28 1993-09-21 Pro-Neuron, Inc. Methods for promoting wound healing with deoxyribonucleosides
DK505488D0 (da) * 1987-12-21 1988-09-09 Bar Shalom Daniel Middel og anvendelse af samme
US5916880A (en) * 1987-12-21 1999-06-29 Bukh Meditec A/S Reduction of skin wrinkling using sulphated sugars
DK86492D0 (da) * 1992-06-30 1992-06-30 Bukh Meditec Laegemiddel
GB9324409D0 (en) * 1993-11-27 1994-01-12 Smithkline Beecham Plc Novel composition
US5783568A (en) * 1994-06-10 1998-07-21 Sugen, Inc. Methods for treating cancer and other cell proliferative diseases
JP4051099B2 (ja) * 1997-01-31 2008-02-20 生化学工業株式会社 低分子化ヘパリン、その製造法及び医薬組成物
AUPO976897A0 (en) * 1997-10-14 1997-11-06 Australian National University, The Use of sulfated oligosaccharides in lowering blood triglyceride levels
GB2362100B (en) * 2000-05-08 2002-05-08 Maelor Pharmaceuticals Ltd Wound gels
CA2495541C (en) * 2002-09-11 2011-07-12 Johnson & Johnson Medical Limited Wound dressing materials comprising complexes of anionic polysaccharides with silver
GB2392913B (en) * 2002-09-11 2007-04-04 Johnson & Johnson Medical Ltd Wound dressings comprising complexes of oxidised celluloses with silver
WO2004062674A2 (en) * 2003-01-07 2004-07-29 Paratek Pharmaceuticals, Inc. Substituted polyamines as inhibitors of bacterial efflux pumps
ES2646813T3 (es) * 2003-06-19 2017-12-18 Coloplast A/S Un dispositivo para el cuidado de heridas
WO2007019554A2 (en) * 2005-08-08 2007-02-15 Momenta Pharmaceuticals, Inc. Polysaccharides for delivery of active agents
DE602005008964D1 (de) * 2005-09-16 2008-09-25 Italfar Societa A Responsabili Wundheilende pharmazeutische Zusammensetzung enthaltend Sucralfat, Glycin, Aluminium Acetat und Vitamine
US8277849B2 (en) * 2006-01-19 2012-10-02 Solazyme, Inc. Microalgae-derived compositions for improving the health and appearance of skin
RU2384338C2 (ru) * 2008-02-13 2010-03-20 Сергей Георгиевич Павленко Композиция для лечения гнойных ран и трофических язв
FR2956322A1 (fr) * 2010-02-17 2011-08-19 Urgo Lab Utilisation d'oligosaccharides polysulfates synthetiques comme agents de detersion d'une plaie.

Also Published As

Publication number Publication date
CA2788350C (fr) 2018-10-16
CA2788350A1 (fr) 2011-08-25
WO2011101594A1 (fr) 2011-08-25
US8940325B2 (en) 2015-01-27
KR20120138742A (ko) 2012-12-26
ES2578327T3 (es) 2016-07-26
JP2013519713A (ja) 2013-05-30
BR112012020739A2 (pt) 2016-04-26
MX2012009675A (es) 2013-02-11
FR2956322A1 (fr) 2011-08-19
JP5889804B2 (ja) 2016-03-22
AU2011217040B2 (en) 2015-03-26
FR2976082A1 (fr) 2012-12-07
JP2016020376A (ja) 2016-02-04
PT2536413T (pt) 2016-08-29
AU2011217040A1 (en) 2012-09-06
FR2976082B1 (fr) 2018-05-04
CN102762212B (zh) 2014-11-26
KR101846036B1 (ko) 2018-05-18
EP2536413A1 (fr) 2012-12-26
EP2536413B1 (fr) 2016-06-01
CN102762212A (zh) 2012-10-31
RU2601899C2 (ru) 2016-11-10
SG182798A1 (en) 2012-09-27
US20130034596A1 (en) 2013-02-07
RU2012137955A (ru) 2014-03-27
PL2536413T3 (pl) 2016-11-30

Similar Documents

Publication Publication Date Title
MX336870B (es) Uso de oligosacaridos sinteticos polisulfatados como agentes de desbridamiento de heridas.
UA107423C2 (en) Fluoro-pyridinone derivatives useful as antibacterial agents
MX344238B (es) Compuestos de tetrazol y métodos para preparar y usar los mismos.
EP2555760A4 (en) METHODS AND COMPOSITIONS FOR TREATING INJURIES USING CHITOSAN COMPOUNDS
MX2015011955A (es) Lipidos y composiciones de lipidos para el suministro de agentes activos.
MY184978A (en) Pyridin-2-amides useful as cb2 agonists
CO6382103A2 (es) Producto de cuidado bucal y metodos de uso y fabricacion del mismo
PL2687094T3 (pl) Wytwarzanie kwasów peroksykarboksylowych w zasadowym pH i ich zastosowanie jako czynniki wybielające tekstylia i czynniki przeciwmikrobiologiczne
MX2013004491A (es) Boronatos como inhibidores de arginasa.
UA106743C2 (uk) Застосування цистеаміну як протимікробного агента
ZA201200859B (en) Ceria for use as an antimicrobial barrier and disinfectant in a wound dressing
GB201118586D0 (en) New A-PRP medical device, manufacturing machine and process
MY162535A (en) Inhibitors of arginase and their therapeutic applications
UA110943C2 (uk) N-ацилсульфонамідні промотори апоптозу
MX2013001919A (es) Producto para el cuidado bucal y metodos de uso y elaboracion del mismo
MY179412A (en) Pyridine-2-amides useful as cb2 agonists
PH12014501693A1 (en) Antimicrobial compositions comprising dgla, 15-ohepa and/or 15-hetre and methods of use thereof
WO2013106761A3 (en) Antimicrobial agents
PL2898881T3 (pl) Kompozycja obejmująca kompleksy nadcząsteczkowe polimerów polianionowych i spermidyny do zastosowania w leczeniu przyzębia i tkanek jamy ustnej
ITMI20120370A1 (it) Miscela antimicrobica e rivestimento per supportare la guarigione di ferite, che ha un effetto antimicrobico.
EP2590689A4 (en) IN SITU TRAINING OF HYDROGEL-BASED HEALING DRESSINGS CONTAINING ANTIMICROBIAL AGENTS
HUP1000362A2 (en) Antiseptic and disinfecting compositions having reduced iodine content
TR201903940T4 (tr) Uzatılmış salımlı etken madde içeren pansuman.
GB0813040D0 (en) Compositions for use as or in wound dressings
MX359713B (es) Composiciones mejoradas para la cicatrizacion de heridas que comprenden microesferas.

Legal Events

Date Code Title Description
FG Grant or registration